• UVA Health has joined two NIH-sponsored clinical trials targeting sleep disorders and autonomic dysfunction in long COVID patients, addressing conditions affecting potentially 50 million Americans.
• The RECOVER-SLEEP trial is testing medications including Solriamfetol and Modafinil for hypersomnia, while also examining light therapy and Melatonin for complex sleep disturbances in post-COVID patients.
• The RECOVER-AUTONOMIC study focuses on treating postural orthostatic tachycardia syndrome (POTS) with intravenous immunoglobulins or ivabradine, alongside non-drug interventions like compression belts and high-salt diets.